Kidswell Bio Corp completes fourth tranche convertible bond exercise

TOKYO, Jul 22 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) completed the exercise of its fourth series of unsubordinated convertible bonds with warrant attached, which was issued on July 14, 2022. During the period from July 1, July 22, 2026 to July 22, 2026, the company saw significant exercises totaling 132 units, bringing the total exercised amount to 125,000 shares.

As of July 22, 2026, all outstanding warrants have been fully exercised. In detail, the initial number of shares delivered since the beginning of the month was 946,969. The cumulative face value of the exercised bonds accounted for 25.00% of the issuance total.

At the end of June 2026, there were ¥125 million remaining unexercised bonds, which decreased to ¥0 by the end of the exercise period. , the final exercise resulted in the delivery of 946,969 shares. Regarding the monthly exercise status, the company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Listing Regulations Article 434 and the Securities Association’s regulations on third-party allotments.

The combined monthly share deliveries amounted to 946,969 shares, representing 2.32% of the listed ordinary shares at the time of issuance, which stood at 40,671,113 shares.